[Extended lymph-node dissection for gastric cancer].

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Chirurgie; memoires de l'Academie de chirurgie

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10615789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

  1996cited by this paper
• Does extensive dissection of lymph nodes improve the results of surgical treatment of gastric cancer?

  1990cited by this paper
• Progress in gastric cancer surgery in Japan and its limits of radicality

  1987cited by this paper

• Historical evolution and current research status of lymph node staging in gastric cancer: a review

  2025cites this paper
• Outcomes of Locally Advanced Gastric Cancer Treated with D2 Gastrectomy and HIPEC

  2025cites this paper
• Escalation and de-escalation in surgery for gastric cancer

  2025cites this paper
• Trastuzumab significantly improves survival in resectable HER-2 positive gastric cancer: A retrospective study

  2025cites this paper
• Comparative Outcomes of Spleen Preservation and Splenectomy in Total Gastrectomy for Proximal Gastric Cancer: A Systematic Review and Meta-Analysis

  2025cites this paper
• Early Post-Operative Complications and Prognosisof Gastric Cancer Surgery

  2025cites this paper
• Evidenz für Ausmaß und onkologischen Nutzen der Lymphadenektomie beim Magenkarzinom

  2024cites this paper
• Optimal lymph node dissection for gastric cancer: a narrative review

  2024influential citation
• Less Than Ten: Defining the Role of Splenic Hilar Lymph Node Dissection in Gastric Cancer

  2023cites this paper
• Epidemiology of Gastric Cancer: Global Trends, Risk Factors and Premalignant Conditions

  2023cites this paper
• Preclinical evaluation of sentinel node localization in the stomach via mannose-labelled magnetic nanoparticles and indocyanine green

  2023cites this paper
• Current standards of surgical management of gastric cancer: an appraisal

  2023cites this paper
• Differences of clinical features and outcomes between male and female elderly patients in gastric cancer

  2023cites this paper
• Higher Numbers of Examined Lymph Nodes Are Associated with Increased Survival in Resected, Treatment-Naïve, Node-Positive Esophageal, Gastric, Pancreatic, and Colon Cancers

  2023cites this paper
• Recent advances for treatment of upper gastrointestinal malignancy

  2023cites this paper
• Surgery Matters: Progress in Surgical Management of Gastric Cancer

  2023cites this paper
• Effects of the preoperative use and dosage of steroids on postoperative complications of gastric cancer surgery

  2023cites this paper
• Gastric Cancer Surgery in the US: a Contemporary Trend Analysis of Lymphadenectomy and the Impact of Minimally Invasive Approaches

  2023cites this paper
• Efficacy of Lymph Node Location-Number Hybrid Staging System on the Prognosis of Gastric Cancer Patients

  2023cites this paper
• The impact of implementing current treatment modalities and female sex on gastric cancer outcomes, 2000–2016: a longitudinal nationwide cohort study

  2023cites this paper
• Incidence and mortality trends in gastric cancer in the United States, 1992‐2019

  2022cites this paper
• Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study

  2022cites this paper
• Clinical Study on the Evaluation of the Condition of Patients with Gastric Tumors and the Choice of Surgical Treatment by Gastric Ultrasonic Filling Method

  2022cites this paper
• pT1-2 gastric cancer with lymph node metastasis predicted by tumor morphologic features on contrast-enhanced computed tomography

  2022cites this paper
• Fifty years of progress in gastric cancer

  2022cites this paper
• Prevalence of nodal metastases in the individual lymph node stations for different T-stages in gastric cancer: a systematic review

  2022cites this paper
• Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials

  2022cites this paper
• Use of folic acid nanosensors with excellent photostability for hybrid imaging

  2022cites this paper
• The Impact of Perioperative Events on Cancer Recurrence and Metastasis in Patients after Radical Gastrectomy: A Review

  2022cites this paper
• Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy

  2022cites this paper
• Vascular Endothelial Growth Factor (VEGF) expression by immunohistochemistry as a prognostic factor in gastric carcinoma

  2022cites this paper
• Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer

  2022cites this paper
• Evolution of treatment in gastric cancer- a systematic review

  2022cites this paper
• Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review

  2022cites this paper
• Gastric Carcinoma—a New Biomarker Peritoneal Fluid Lavage Cytology

  2022cites this paper
• The Association of Race With Adequate Lymph Node Evaluation for Gastric Cancer

  2022cites this paper
• Is D2 laparoscopic gastrectomy essential for elderly patients with advanced gastric cancer?

  2022cites this paper
• Impact of the introduction of formal D2 lymphadenectomy for gastric cancer in a Western setting

  2021cites this paper
• Systematic evaluation of the safety and therapeutic effects of para-aortic lymphadenectomy for advanced gastric cancer: a systematic review and meta-analysis.

  2021cites this paper
• Efficacy and toxicity of capecitabine combined with intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with gastric cancer

  2021cites this paper
• Risk of Lymph Node Metastasis in T1b Gastric Cancer

  2021cites this paper
• The metastatic lymph node ratio is a better prognostic factor than the number of metastatic limph node after curative resection for gastric cancer

  2021cites this paper
• The efficiency of D1(+) lymphadenectomy in signet ring cell carcinoma: comparison of postoperative early and late outcomes between standard lymphadenectomy and D1(+) lymphadenectomy

  2021cites this paper
• Patterns of care and outcomes for gastric and gastro‐oesophageal junction cancer in an Australian population

  2021cites this paper
• Clinical Outcomes Following Regionalization of Gastric Cancer Care in a US Integrated Health Care System

  2021cites this paper
• Shifting sands: the role of radiotherapy for patients with gastric and gastroesophageal adenocarcinoma.

  2021cites this paper
• Advances in the surgical management of gastric and gastroesophageal junction cancer.

  2021cites this paper
• The 140 years' journey of gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot

  2021cites this paper
• Compliance with D2 lymph node dissection in reduced-port totally laparoscopic distal gastrectomy in patients with gastric cancer

  2021cites this paper
• Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors

  2021cites this paper
• Pancreatic Fistula after D1+/D2 Radical Gastrectomy according to the Updated International Study Group of Pancreatic Surgery Criteria: Risk Factors and Clinical Consequences. Experience of Surgeons with High Caseloads in a Single Surgical Center in Eastern Europe

  2021cites this paper
• Surgical Management of Gastric Cancer: A Systematic Review

  2021cites this paper
• Postprandial Asymptomatic Glycemic Fluctuations after Gastrectomy for Gastric Cancer Using Continuous Glucose Monitoring Device

  2021cites this paper
• Minimally invasive versus open surgery for gastric cancer in Turkish population.

  2021cites this paper
• Oesophageal and Gastric Cancer. Aspects on treatment strategies, outcome after surgery and prognostic biomarkers

  2020cites this paper
• Minimally invasive gastrectomy for cancer and anastomotic options

  2020cites this paper
• Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis

  2020cites this paper
• Textbook Outcome and Survival in Patients With Gastric Cancer

  2020cites this paper
• Significance of nodal dissection and nodal positivity in gastric cancer.

  2020cites this paper
• Atlas of Lymphoscintigraphy and Sentinel Node Mapping: A Pictorial Case-Based Approach

  2020cites this paper
• Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells

  2020cites this paper
• Progress in the treatment of gastric cancer in Japan over the last 50 years

  2020cites this paper
• Risk factors and a predictive nomogram for lymph node metastasis of superficial esophagogastric junction cancer

  2020cites this paper
• D2 vs D2 Plus Para-aort c Lymph Node D ssect on for Advanced Gastr c Cancer

  2020cites this paper
• Operative and Oncological Outcomes After D2 Versus D1 Gastrectomy of Operable Gastric Cancer: an Observational Study

  2020cites this paper
• ICG‐NIR‐guided lymph node dissection during robotic subtotal gastrectomy for gastric cancer. A single‐centre experience

  2020cites this paper
• D2 vs D2 Plus Para-aortic Lymph Node Dissection for Advanced Gastric Cancer.

  2020influential citation
• Determinants of surgical morbidity in gastric cancer: experience of a single center and literature review

  2020cites this paper
• Perioperative Docetaxel, Oxaliplatin, Fluorouracil, and Leucovorin (FLOT) in Patients with Gastric or Esophagogastric Junction Adenocarcinoma; Real-Life Experience

  2020cites this paper
• Current perspectives on the safety and efficacy of robot-assisted surgery for gastric cancer

  2020cites this paper
• Postoperative Morbidity and Failure to Rescue in Surgery for Gastric Cancer: A Single Center Retrospective Cohort Study of 1107 Patients from 1972 to 2014

  2020cites this paper
• A study of outcomes, technical safety, and feasibility of D‐2 lymphadenectomy in gastric cancer

  2020cites this paper
• Phase II Study of Capecitabine Combined With Intensity-Modulated Radiotherapy After D1/D2 Lymph Node Dissection in Patients with Gastric Cancer

  2020cites this paper
• Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery

  2020cites this paper
• Burgeoning study of sentinel-node analysis on management of early gastric cancer after endoscopic submucosal dissection

  2020cites this paper
• Proposal of a novel stage grouping of the Eighth Edition of American Joint Committee on Cancer TNM Staging System for Gastric Cancer: results from a retrospective study of 30 years clinical data from a single institute in China

  2020cites this paper
• Omental Free-Shaped Flap Reinforcement on Anastomosis and Dissected Area (OFFROAD) Following Reconstruction after Gastrectomy: A Retrospective Case-Control Study

  2020cites this paper
• Brazilian Group of Gastrointestinal Tumours’ consensus guidelines for the management of gastric cancer

  2020cites this paper
• Laparoscopic versus open approach in gastrectomy for advanced gastric cancer: a systematic review

  2020cites this paper
• GI Surgery Annual

  2019cites this paper
• Fluorescent Lymphography–Guided Lymphadenectomy During Robotic Radical Gastrectomy for Gastric Cancer

  2019cites this paper
• Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage

  2019cites this paper
• S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL

  2019cites this paper
• Long-term Survival Outcomes of Laparoscopic Gastrectomy for Advanced Gastric Cancer: Five-year Results of a Phase II Prospective Clinical Trial

  2019cites this paper
• Subcutaneous Metastasis of Gastric Cancer at Left Axilla: A Case Report and Literature Review

  2019cites this paper
• An examination of surgical and survival outcomes in the elderly (65–79 years of age) and the very elderly (≥80 years of age) who received surgery for gastric cancer

  2019cites this paper
• Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy

  2019cites this paper
• Evaluating Dissemination of Adequate Lymphadenectomy for Gastric Cancer in the USA

  2019cites this paper
• Left armpit subcutaneous metastasis of gastric cancer: A case report

  2019cites this paper
• Current role of lymphadenectomy in gastric cancer surgery.

  2019cites this paper
• Role of Postoperative Complications in Overall Survival after Radical Resection for Gastric Cancer: A Retrospective Single-Center Analysis of 1107 Patients

  2019cites this paper
• Bedeutung der Splenektomie im Rahmen der operativen Behandlung des Magenkarzinoms

  2019cites this paper
• Post-operative morbidity and mortality following D2 gastrectomy in a state funded tertiary care centre in South India

  2019cites this paper
• The role of sentinel lymph node detection in early gastric cancer – literature review

  2019cites this paper
• Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer

  2019cites this paper
• Predicting overall and major postoperative morbidity in gastric cancer patients

  2019cites this paper
• Adjuvant Radiochemotherapy versus Chemotherapy Alone for Gastric Cancer: Implications for Target Definition

  2019cites this paper
• Lymphadenectomy in Locally Advanced Gastric Cancer

  2019cites this paper
• Prognostic Impact of Extended Lymph Node Dissection versus Limited Lymph Node Dissection on pN0 Proximal Advanced Gastric Cancer: a Propensity Score Matching Analysis

  2019cites this paper
• The optimal strategy of multimodality therapies for resectable gastric cancer: evidence from a network meta-analysis

  2019cites this paper